Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 3501 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3502 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3503 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3504 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3505 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3506 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3507 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3508 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3509 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3510 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3511 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3512 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | 0 |
| 3513 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3514 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3515 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3516 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | 0 |
| 3517 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 5 |
| 3518 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 9 |
| 3519 | Cord Blood | Allogeneic – Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7 |
| 3520 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4 |
| 3521 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 3 |
| 3522 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 5 |
| 3523 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
| 3524 | Cord Blood | Allogeneic – Related | Autism | Neurology | 2021 | Experimental Therapy | Germany | 8 |
| 3525 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 9 |
| 3526 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
| 3527 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 6 |
| 3528 | Cord Blood | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 9 |
| 3529 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6 |
| 3530 | Cord Blood | Allogeneic – Related | Diamond Blackfan Anemia | Hematology | 2021 | Standard Therapy | Turkey | 3 |
| 3531 | Cord Blood | Autologous | Fanconi Anemia | Hematology | 2021 | Standard Therapy | Germany | 7 |
| 3532 | Cord Blood | Allogeneic – Related | Immune Failure-Cd40 L Deficiency | Hematology | 2021 | Standard Therapy | Turkey | 12 |
| 3533 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 5 |
| 3534 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16 |
| 3535 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 7 |
| 3536 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16 |
| 3537 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Slovakia | 4 |
| 3538 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 3539 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 33 |
| 3540 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 3541 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 3542 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 3543 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3544 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 3545 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 3546 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 3547 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 3548 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3549 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 3550 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3551 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 3552 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 3553 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3554 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 3555 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
| 3556 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3557 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 36 |
| 3558 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 39 |
| 3559 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 71 |
| 3560 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3561 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3562 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 3563 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 3564 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 3565 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 3566 | Bone Marrow Family | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 3567 | Bone Marrow Family | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3568 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 3569 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
| 3570 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3571 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 8 |
| 3572 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3573 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 3574 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 3575 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 3576 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3577 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 3578 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 3579 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 3580 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3581 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3582 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3583 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3584 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3585 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
| 3586 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 3587 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 15 |
| 3588 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3589 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2021 | Standard Therapy | Poland | 8 |
| 3590 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 3591 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 19 |
| 3592 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
| 3593 | Bone Marrow | Allogeneic | Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 3594 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 16 |
| 3595 | Bone Marrow | Allogeneic | Bcr-Abl Pos. All | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 3596 | Bone Marrow | Allogeneic | Beta Thalassemia Major | Hematology | 2021 | Standard Therapy | Poland | 14 |
| 3597 | Bone Marrow | Allogeneic | Cartilage Hair Hypoplasia | Orthopedics | 2021 | Standard Therapy | Poland | 7 |
| 3598 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3599 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3600 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |